https://doi.org/10.4081/cardio.2024.41

Global Cardiology issue highlights

Vol. 2 No. 2 (2024)
Published: June 28, 2024
Global Cardiology, editorial
Abstract Views: 2608
PDF: 339
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Andrew J.S. Coats
ajscoats@aol.com
Heart Research Institute, Sydney, Australia.

Welcome to the June issue of Global Cardiology, a journal devoted to the dissemination of knowledge, impact and research of relevance to cardiovascular physicians and healthcare professionals worldwide. True to this purpose, we are pleased to introduce diverse and stimulating contributions and comments [...].

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

Crossref
Scopus
Google Scholar
Europe PMC
Khachfe HH, Refaat MM. Bibliometric analysis of cardiovascular disease research activity in the Arab world. Global Cardiol 2024;2:34.
Refaat MM, El Jamal N, El-Rayess HM, Gebran A, Salam AM. The impact of diurnal fasting during Ramadan on patients with established cardiac disease: a systematic review. Global Cardiol 2024;2:32.
Karaye KM, Habib AG, Sliwa K. Epidemiology of peripartum cardiomyopathy in Africa. Global Cardiol 2024;2:31.
Karaye KM, Mohammed IY, Sa'idu H, et al. Prevalence of left ventricular dysfunction and relationship with serum selenium in apparently healthy pregnant women: results from the PEACE registry. Global Cardiol 2024;2:36.
von Bardeleben RS, Shahzeb Khan M, Geyer M, et al. Baseline echocardiographic characteristics of patients enrolled in the randomized investigation of MitraClip device in heart failure (RESHAPE HF-2) trial: comparison to COAPT and Mitra-FR. Global Cardiol 2024;2:40.
Anker SD, Butler J, Talha KM, Friede T. Using multiple primary endpoints in clinical trials with a focus on heart failure. Global Cardiol 2024;2:33.
Shariq Usman M, Hamid A, Qazi SU, et al. The effect of SGLT2 inhibitors on health status in patients with heart failure. Global Cardiol 2024;2:35.
Butler J, Shah SJ, Magwire M, et al. Treatment pathways in patients with heart failure with preserved ejection fraction and obesity: perspectives from cardiology specialists and patients. Global Cardiol 2024;2:38. DOI: https://doi.org/10.4081/cardio.2024.38
Salzillo C, Giovannico L, Fischetti G, et al. Preliminary study on the immunohistochemical expression of galectin-3 in hypertrophic hearts. Global Cardiol 2024;2:37. DOI: https://doi.org/10.20944/preprints202309.1187.v1
Aland SC, Gertler C, Bräunig HL, et al. Exercise capacity, iron deficiency and depressive symptoms in patients with asymptomatic chronic systolic heart failure. Global Cardiol 2024;2:39. DOI: https://doi.org/10.4081/cardio.2024.39

How to Cite

Coats, A. J. (2024). Global Cardiology issue highlights. Global Cardiology, 2(2). https://doi.org/10.4081/cardio.2024.41
Copyright (c) 2024 the Author(s) Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.